Free Trial

Humana (HUM) Competitors

$358.93
+0.83 (+0.23%)
(As of 06/14/2024 ET)

HUM vs. ELV, CI, CNC, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUE

Should you be buying Humana stock or one of its competitors? The main competitors of Humana include Elevance Health (ELV), The Cigna Group (CI), Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.

Humana vs.

Elevance Health (NYSE:ELV) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$171.34B0.72$5.99B$26.4620.20
Humana$106.37B0.41$2.49B$16.0622.34

Humana received 45 more outperform votes than Elevance Health when rated by MarketBeat users. However, 66.85% of users gave Elevance Health an outperform vote while only 63.97% of users gave Humana an outperform vote.

CompanyUnderperformOutperform
Elevance HealthOutperform Votes
839
66.85%
Underperform Votes
416
33.15%
HumanaOutperform Votes
884
63.97%
Underperform Votes
498
36.03%

In the previous week, Humana had 3 more articles in the media than Elevance Health. MarketBeat recorded 26 mentions for Humana and 23 mentions for Elevance Health. Humana's average media sentiment score of 0.77 beat Elevance Health's score of 0.24 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
10 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Humana
7 Very Positive mention(s)
1 Positive mention(s)
17 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.4% of Elevance Health shares are owned by company insiders. Comparatively, 0.3% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Elevance Health has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500.

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.0%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. Humana pays out 22.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 13 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.82%. Humana's return on equity of 20.62% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health3.64% 20.62% 7.35%
Humana 1.82%17.76%5.63%

Elevance Health presently has a consensus price target of $607.36, indicating a potential upside of 13.65%. Humana has a consensus price target of $423.63, indicating a potential upside of 18.05%. Given Elevance Health's higher possible upside, analysts plainly believe Humana is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
3.00
Humana
0 Sell rating(s)
12 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.43

Summary

Elevance Health beats Humana on 16 of the 22 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUM vs. The Competition

MetricHumanaHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$43.15B$65.31B$5.22B$17.74B
Dividend Yield0.99%1.35%2.78%3.59%
P/E Ratio22.3411.8895.7619.87
Price / Sales0.410.552,184.1814.24
Price / Cash10.4510.0134.4319.58
Price / Book2.713.934.854.80
Net Income$2.49B$3.04B$110.78M$978.08M
7 Day Performance2.00%-1.21%-0.40%0.67%
1 Month Performance3.37%-3.40%-2.08%-4.25%
1 Year Performance-22.64%11.29%0.08%6.28%

Humana Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.4862 of 5 stars
$536.93
+0.1%
$605.93
+12.9%
+22.5%$124.79B$171.34B20.29104,900Analyst Forecast
CI
The Cigna Group
4.9591 of 5 stars
$337.94
-0.2%
$373.87
+10.6%
+26.4%$96.00B$204.15B27.7572,500Analyst Downgrade
Insider Selling
News Coverage
CNC
Centene
4.7254 of 5 stars
$69.27
-0.8%
$84.93
+22.6%
+6.6%$36.97B$154.00B13.7767,700Analyst Upgrade
Short Interest ↑
MOH
Molina Healthcare
4.9719 of 5 stars
$312.28
+1.4%
$407.45
+30.5%
+11.5%$18.30B$34.07B16.94123,123Short Interest ↑
UNH
UnitedHealth Group
4.9608 of 5 stars
$496.23
+0.2%
$578.75
+16.6%
+8.0%$456.73B$371.62B30.33440,000Analyst Upgrade
OSCR
Oscar Health
1.8894 of 5 stars
$20.02
-2.4%
$18.57
-7.2%
+108.2%$4.75B$5.86B-50.042,400Analyst Forecast
Short Interest ↑
Positive News
ALHC
Alignment Healthcare
1.3985 of 5 stars
$8.26
-1.3%
$9.20
+11.4%
+28.6%$1.58B$1.82B-9.831,536Insider Selling
Short Interest ↑
News Coverage
TRUP
Trupanion
2.4544 of 5 stars
$28.42
+1.4%
$32.80
+15.4%
+6.2%$1.19B$1.16B-44.411,142Positive News
CLOV
Clover Health Investments
1.9597 of 5 stars
$1.03
+4.0%
$1.50
+45.6%
+15.8%$511.33M$2.03B-3.03552Short Interest ↓
NEUE
NeueHealth
2.7229 of 5 stars
$5.63
+0.9%
$8.00
+42.1%
N/A$46.30M$1.11B-0.041,252Short Interest ↓
News Coverage
Positive News
Gap Up

Related Companies and Tools

This page (NYSE:HUM) was last updated on 6/15/2024 by MarketBeat.com Staff

From Our Partners